Continue to Site

GSK’s CEO and CFO Discuss the Company’s Second Quarter Results

By Pharmaceutical Processing | July 23, 2014

GSK CEO Sir Andrew Witty and CFO Simon Dingemans on the group’s Q2 2014 results and strategy update.

Market Summary > Current Price

The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Search Pharmaceutical Processing World